GEN News Highlights: Dec 2, 2010

G-Con and GE Healthcare Team Up for Modular Biotherapeutic Manufacturing Solution

(Page 1 of 1)

    G-Con Manufacturing and GE Healthcare have joined forces on the development of a modular portable bioprocess manufacturing solution for vaccines and therapeutics. The collaboration combines GE Healthcare’s global presence and expertise in biopharmaceutical manufacturing technology with G-Con’s modular portable flexible cleanroom technology.

    The aim is to provide more affordable comprehensive GMP manufacturing solutions that are quicker to build, maintain, and operate in facilities worldwide. The companies believe that their alliance will also be able to meet the growing market for rapid access to biopharmaceutical manufacturing capabilities, whether in developing markets or to increase the speed in situations such as a pandemic response.

    “This collaboration is part of GE Healthcare’s mission to increase speed and access and reduce cost for developers and manufacturers of biotherapeutics and vaccines around the world,” says Nigel Darby, vp of biotechnologies at GE Healthcare. “This collaboration means we move further towards our vision of modular and possibly mobile flexible biopharmaceutical manufacturing facilities—the vaccine factory in a box.”

    G-Con Manufacturing is dedicated to bringing new technologies and processes to the therapeutic manufacturing industry by providing comprehensive GMP manufacturing solutions that are less expensive, more flexible, and efficient to operate than any existing solution on the market.

    Meanwhile, GE Healthcare provides transformational medical technologies and services and has a broad expertise in medical imaging, information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement, and performance solutions.

Add GEN to your Inbox FREE!

Subscribe to our daily and weekly e-Newsletters to get our biotech news coverage delivered to your inbox.



Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Republican Candidates

Which Republican nominee do you think is most supportive of the biopharma industry?

Suggest a Poll